Table 2. | Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice

Open accessCopyright infoDownload PDFDownload figures

Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice

Table 2.

Affiliation details

University of Washington, United States; Fred Hutchinson Cancer Research Center, United States; University of Missouri, United States
Table 2.

Sex-segregated comparison of median and mean lifespan for mice receiving rapamycin by injection (8 mg/kg/day) or feeding (128 ppm). M: males, F: females.

DOI: http://dx.doi.org/10.7554/eLife.16351.009

Median lifespan (days)Percent median lifespan increaseMean lifespan (days)Percent mean lifespan increase
Vehicle M925929
Rapamycin (8mg/kg/day) M105414105013
Vehicle F847858
Rapamycin (8mg/kg/day) F8470853-1
Eudragit M914912
Rapamycin (126 ppm) M1037149848
Eudragit F879883
Rapamycin (126 ppm) F96099518